BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22193914)

  • 1. Expanding the clinical and genetic spectrum of human CD40L deficiency: the occurrence of paracoccidioidomycosis and other unusual infections in Brazilian patients.
    Cabral-Marques O; Schimke LF; Pereira PV; Falcai A; de Oliveira JB; Hackett MJ; Errante PR; Weber CW; Ferreira JF; Kuntze G; Rosário-Filho NA; Ochs HD; Torgerson TR; Carvalho BT; Condino-Neto A
    J Clin Immunol; 2012 Apr; 32(2):212-20. PubMed ID: 22193914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis.
    Cabral-Marques O; Arslanian C; Ramos RN; Morato M; Schimke L; Soeiro Pereira PV; Jancar S; Ferreira JF; Weber CW; Kuntze G; Rosario-Filho NA; Costa Carvalho BT; Bergami-Santos PC; Hackett MJ; Ochs HD; Torgerson TR; Barbuto JA; Condino-Neto A
    J Allergy Clin Immunol; 2012 Mar; 129(3):778-86. PubMed ID: 22154528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients.
    Tsai HY; Yu HH; Chien YH; Chu KH; Lau YL; Lee JH; Wang LC; Chiang BL; Yang YH
    J Microbiol Immunol Infect; 2015 Feb; 48(1):113-8. PubMed ID: 23010537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.
    Gallagher J; Adams J; Hintermeyer M; Torgerson TR; Lopez-Guisa J; Ochs HD; Szabo S; Salib M; Verbsky J; Routes J
    J Clin Immunol; 2016 Aug; 36(6):564-70. PubMed ID: 27324886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel hemizygous CD40L mutation of X-linked hyper IgM syndromes and compound heterozygous DOCK8 mutations of hyper IgE syndromes in two Chinese families.
    Guo M; Ma Y; Cai K; Liu X; Liu W; Wang F; Qu N; Liu S
    Immunogenetics; 2024 Jun; 76(3):165-173. PubMed ID: 38587548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
    Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
    Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked hyper-IgM syndrome associated with pulmonary manifestations: A very rare case of functional mutation in CD40L gene in Iran.
    Torabizadeh M; Nabavi M; Zadkarami M; Shahrooei M
    Curr Res Transl Med; 2019 Feb; 67(1):28-30. PubMed ID: 29525420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China.
    An Y; Xiao J; Jiang L; Yang X; Yu J; Zhao X
    Scand J Immunol; 2010 Jul; 72(1):50-6. PubMed ID: 20591076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked hyper-immunoglobulin M syndrome harboring a novel CD40-ligand gene mutation: a case report.
    Ramachandran R; Krishnan Y; Singh P; Kumar A; Mohanty A
    Immunogenetics; 2023 Apr; 75(2):191-194. PubMed ID: 36478253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked hyper IgM syndrome: clinical, immunological and molecular features in patients from India.
    Madkaikar M; Gupta M; Chavan S; Italia K; Desai M; Merchant R; Radhakrishnan N; Ghosh K
    Blood Cells Mol Dis; 2014 Sep; 53(3):99-104. PubMed ID: 24929972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
    Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
    Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis.
    Lopez-Granados E; Temmerman ST; Wu L; Reynolds JC; Follmann D; Liu S; Nelson DL; Rauch F; Jain A
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5056-61. PubMed ID: 17360404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial DNA insert into CD40 ligand gene-associated X-linked hyper-IgM syndrome.
    Li X; Xu D; Cheng B; Zhou Y; Chen Z; Wang Y
    Mol Genet Genomic Med; 2021 May; 9(5):e1646. PubMed ID: 33764006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome.
    Wang LL; Zhou W; Zhao W; Tian ZQ; Wang WF; Wang XF; Chen TX
    J Immunol Res; 2014; 2014():683160. PubMed ID: 25215306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes.
    Cabral-Marques O; Klaver S; Schimke LF; Ascendino ÉH; Khan TA; Pereira PV; Falcai A; Vargas-Hernández A; Santos-Argumedo L; Bezrodnik L; Moreira I; Seminario G; Di Giovanni D; Raccio AG; Porras O; Weber CW; Ferreira JF; Tavares FS; de Carvalho E; Valente CF; Kuntze G; Galicchio M; King A; Rosário-Filho NA; Grota MB; dos Santos Vilela MM; Di Gesu RS; Lima S; de Souza Moura L; Talesnik E; Mansour E; Roxo-Junior P; Aldave JC; Goudouris E; Pinto-Mariz F; Berrón-Ruiz L; Staines-Boone T; Calderón WO; del Carmen Zarate-Hernández M; Grumach AS; Sorensen R; Durandy A; Torgerson TR; Carvalho BT; Espinosa-Rosales F; Ochs HD; Condino-Neto A
    J Clin Immunol; 2014 Feb; 34(2):146-56. PubMed ID: 24402618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polymorphism p.G219R of CD40L does not cause immunological alterations in vivo: conclusions from a X-linked hyper IgM syndrome kindred.
    Martinez-Martinez L; Gonzalez-Santesteban C; Badell I; de la Calle-Martin O
    Mol Immunol; 2012 Oct; 52(3-4):237-41. PubMed ID: 22750225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
    Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
    Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
    Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
    J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.
    López-Herrera G; Maravillas-Montero JL; Vargas-Hernández A; Berrón-Ruíz L; Ramírez-Sánchez E; Yamazaki-Nakashimada MA; Espinosa-Rosales FJ; Santos-Argumedo L
    Immunol Res; 2015 May; 62(1):89-94. PubMed ID: 25752457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome.
    Hubbard N; Hagin D; Sommer K; Song Y; Khan I; Clough C; Ochs HD; Rawlings DJ; Scharenberg AM; Torgerson TR
    Blood; 2016 May; 127(21):2513-22. PubMed ID: 26903548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.